Screener
Pfizer PFE Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Pfizer’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 7:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000078003-26-000054
FAQ
- What is Pfizer's other non-current liabilities?
- Pfizer (PFE) reported other non-current liabilities of $14.2B in Q1 2026.
- How has Pfizer's other non-current liabilities changed year-over-year?
- Pfizer's other non-current liabilities increased by 6.8% year-over-year, from $13.3B to $14.2B.
- What is the long-term trend for Pfizer's other non-current liabilities?
- Over 5 years (2020 to 2025), Pfizer's other non-current liabilities has grown at a 17.2% compound annual growth rate (CAGR), from $6.67B to $14.73B.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Pfizer's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude